SPY330.06+1.27 0.39%
DIA268.41+1.69 0.63%
IXIC10,941.17+38.37 0.35%

Ocular Therapeutix Q3 EPS $(0.45) Beats $(0.47) Estimate, Sales $829K Beat $580K Estimate

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.47) by 4.26 percent. This is a 18.42 percent decrease over losses of $(0.38) per share from

Benzinga · -

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.47) by 4.26 percent. This is a 18.42 percent decrease over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $829 thousand which beat the analyst consensus estimate of $580 thousand by 42.93 percent. This is a 66.47 percent increase over sales of $498 thousand the same period last year.